Navigation Links
McKesson Corporation Agrees to Pay More Than $13 Million to Settle Claims That It Failed to Report Suspicious Sales of Prescription Medications
Date:5/2/2008

llegal online prescriptions. The pharmacies filled purported online "prescriptions" for hydrocodone (contained in drugs such as Vicodin), but the prescriptions were issued outside the normal course of professional practice and not for a legitimate medical purpose. The United States Attorneys allege that the orders that McKesson received from these pharmacies were unusually large, unusually frequent, and/or deviated substantially from the normal pattern. As a result, millions of dosage units of controlled substances were diverted from legitimate channels of distribution.

"By failing to report suspicious orders for controlled substances that it received from rogue Internet pharmacies, the McKesson Corporation fueled the explosive prescription drug abuse problem we have in this country," said DEA Acting Administrator Michele M. Leonhart. "This civil penalty demonstrates the strong action DEA is taking to cut off the drug supply to pharmacies engaged in Internet diversion schemes."

The Controlled Substances Act is the primary federal law regulating the flow of controlled substances into the marketplace for medical purposes. Among other requirements, the Act requires that distributors register with DEA to sell controlled substances to retail pharmacies and report to DEA suspicious orders or the theft or significant loss of controlled substances. The Act authorizes the imposition of up to a $10,000 civil penalty for each violation of the reporting requirement.

The civil penalty will be collected by the U.S. Attorney's Office in each of the following districts, in the amounts indicated:

Middle District of Florida $7,456,000

District of Maryland $2,000,000

District of Colorado $1,000,000

Southern District of Texas $2,000,000

District of Utah $ 544,000

Eastern District of California $ 250,000

The settlement agreement is neither an admission of liability by McKesson nor a concession by the United
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
2. McKesson Corporation CEO to Address the Detroit Economic Club on Preserving Our Healthcare System and Improving Quality of Life
3. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 8, 2008
4. Service Corporation International Announces Schedule for Its First Quarter 2008 Earnings Release and Conference Call
5. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
6. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
7. Psychemedics Corporation Announces First Quarter Results
8. Nihon LocalSoft Designs New Japanese Software for IRadimed Corporations Award-Winning MRidium MRI Infusion System
9. BioElectronics Corporation Announces New Website for Italian Market
10. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
11. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- Researchers say they have used human embryonic stem ... sperm. While this had already been done using ... these types of cells -- called primordial germ cells ... according to the team at the University of Cambridge ... is one of the earliest events during early mammalian ...
(Date:12/24/2014)... Angeles, CA (PRWEB) December 24, 2014 ... wreak havoc on those who have an intolerance to ... to diarrhea, gas, bloating, migraine headaches, joint pain and ... gluten free diet plans that deliver safe and ... certain foods that trigger a gluten allergy reaction. These ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 The ... is a professional and in-depth research report on ... introduces COC basic information, including its definition, classification, ... news analysis, etc. This report also presents product ... Production is separated by regions, technology and applications. ...
(Date:12/24/2014)... For nearly 20 years, June Cotner has ... and all of life's rites of passage. Here, she ... Ling, in Toasts: The Perfect Words to Celebrate ... Organized by category and containing many original toasts written ... this timely tome contains sayings famous and profound, suitable ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 As 2014 ... reminds homeowners that before investing time and money into ... a licensed professional that specializes in tankless and eco-friendly ... to replace their water heater in 2015 to research ... decision. , Greenstar Home Services specializes in ...
Breaking Medicine News(10 mins):Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2
... , EXTON, Pa., July 29 Kensey Nash Corporation (Nasdaq: ... results for its fourth quarter and fiscal year ended June 30, 2009 ... , , Joe Kaufmann, President and CEO, will be ... at 9:00 A.M. Eastern Time. , , ...
... American Association ... ... in Cancer Prevention Research , a journal of the American Association for Cancer Research, ... head and neck. Furthermore, African Americans had far less HPV infection than whites, which led ...
... , , , ARMONK, ... ) announced today that St. Elizabeth Healthcare is ... roll-out of electronic medical records to improve patient care and lower costs. ... ) , , Today, only 1.5 percent of U.S. hospital ...
... , COLUMBUS, Ohio, July 29 ... New Drug Application (ANDA) for Risperidone Oral Solution, 1mg/mL by ... in 30mL bottles for immediate shipment to wholesalers and pharmacies ... Solution, 1mg/mL are AA rated to RISPERDAL(R) (risperidone) oral solution. ...
... ... and share , ... Skokie, Ill. (Vocus) July 29, 2009 -- Tabyat Partners, LLC. ( www.tabyat.com ), a ... its Web-based communication portal iluvmydoc.com™ ( www.iluvmydoc.com ). The site offers interactive services to ...
... , BOSTON, July 29 Although acne ... extremely common in adult women. Studies show that acne affects more ... more than 25 percent of women between the ages of 40-49 ... to report having acne than men. While there is no cure ...
Cached Medicine News:Health News:Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference 2Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 2Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 3Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 4Health News:St. Elizabeth Healthcare Drives Kentucky's Largest Electronic Medical Records Initiative With IBM 2Health News:St. Elizabeth Healthcare Drives Kentucky's Largest Electronic Medical Records Initiative With IBM 3Health News:Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL 2Health News:Tabyat Partners, LLC. Launches iluvmydoc.com™, to Better Connect Patients with Doctors 2Health News:Hormonal Therapies Offer Effective Solutions for Many Adult Women With Acne 2Health News:Hormonal Therapies Offer Effective Solutions for Many Adult Women With Acne 3Health News:Hormonal Therapies Offer Effective Solutions for Many Adult Women With Acne 4
(Date:12/24/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE MKT: ... biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... the Company achieved the Public Notice (Gong Shi) ... of TPI,s Qionglai Facility (QLF) from the China ... period is a significant procedure of GMP certification ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... MONMOUTH JUNCTION, N.J. , Dec. 22, 2014 ... immunotherapy company marketing its CytoSorb® blood purification technology ... cardiac surgery patients in 28 countries worldwide, today ... Di Russo , MD, FACS, as its Senior ... 2015. Dr. Di Russo ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... SHANGHAI, Oct. 24, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation ... "Company"), a leading China-based pharmaceutical and biotechnology research ... has, through its main Chinese subsidiary, Shanghai ChemPartner ... River Laboratories International, Inc.,s ("Charles River") Shanghai research ...
... and HOPKINTON, Mass., Oct. 24, 2011 DxTerity ... (NASDAQ: CALP ) announced today that ... strategic collaboration that will allow researchers to perform DxTerity,s ... platform minimizing sample processing time without compromising data quality. ...
Cached Medicine Technology:ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Caliper's LabChip® Dx Platform 2DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Caliper's LabChip® Dx Platform 3DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Caliper's LabChip® Dx Platform 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: